Facilitating Innovation through Novel Approaches to Licensing and Oversight of Medical Radioisotope Facilities
Office of Nuclear Reactor Regulation
Describe the NRC’s role in the establishment of a domestic supply of molybdenum-99 (Mo-99), which is primarily produced in a fragile supply chain dependent on ageing international reactors and foreign suppliers.
Highlight the NRC’s success in performing efficient and timely reviews of novel technologies, maintaining communication with interested stakeholders, and supporting U.S. policy objectives.
NRC guidance development, novel regulatory approaches, licensing milestones, and accomplishments.
The NRC’s licensing and oversight activities are supporting U.S. national security and nuclear nonproliferation policy objectives by contributing to the establishment of a domestically-available and reliable supply of Mo-99 without the use of highly-enriched uranium.
Page Last Reviewed/Updated Monday, December 28, 2020